Foundry120 atlas

Erratum: Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease

Download from source ↗

Dataset overview

Participants 20
Samples 20
Reuse readiness 4.6/10 evidence-backed score

Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.

Abstract

<h4>Background</h4>The global alteration of the gut microbial community (dysbiosis) plays an important role in the pathogenesis of inflammatory bowel diseases (IBDs). However, bacterial species that characterize dysbiosis in IBD remain unclear. In this study, we assessed the alteration of the fecal microbiota profile in patients with Crohn's disease (CD) using 16S rRNA sequencing.<h4>Summary</h4>Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing. The V3-V4 hypervariable regions of 16S rRNA were sequenced by the Illumina MiSeq™II system. The average of 62,201 reads per CD sample was significantly lower than the average of 73,716 reads per control sample. The genera Bacteroides, Eubacterium, Faecalibacterium and Ruminococcus significantly decreased in CD patients as compared to healthy controls. In contrast, the genera Actinomyces and Bifidobacterium significantly increased in CD patients. At the species level, butyrate-producing bacterial species, such as Blautia faecis, Roseburia inulinivorans, Ruminococcus torques, Clostridium lavalense, Bacteroides uniformis and Faecalibacterium prausnitzii were significantly reduced in CD patients as compared to healthy individuals (p < 0.05). These results of 16S rRNA sequencing were confirmed in additional CD patients (n = 68) and in healthy controls (n = 46) using quantitative PCR. The abundance of Roseburia inulinivorans and Ruminococcus torques was significantly lower in C-reactive protein (CRP)-positive CD patients as compared to CRP-negative CD patients (p < 0.05).<h4>Key message</h4>The dysbiosis of CD patients is characterized by reduced abundance of multiple butyrate-producing bacteria species.

Study facts

Organism
Platform
Illumina MiSeq II
Age group
Disease groups
Crohn's disease, Non-IBD controls
Anatomical sites

Data availability

Specific data assets have not been resolved from the source yet — see the source repository below for the full file listing.

Strengths & limitations for reuse

Strengths

  • Participant counts are documented
  • Sample counts are documented

Limitations

  • Not documented: raw reads are advertised
  • Not documented: feature/otu tables are advertised
  • Not documented: taxonomic tables are advertised
Extraction evidence & provenance

Each extracted field is shown with the source excerpt and location used to resolve it.

Assay

FieldValueEvidence
assay.platform Illumina MiSeq II
were sequenced by the Illumina MiSeq™II system.

Section descriptions[0], offset 4520

assay.sequencing_type amplicon_16s
using 16S rRNA sequencing

Section descriptions[0], offset 4300

assay.target_region V3-V4
The V3-V4 hypervariable regions of 16S rRNA were sequenced

Section descriptions[0], offset 4450

Cohort

FieldValueEvidence
cohort.crohns_disease_participants 10
Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing.

Section descriptions[0], offset 4300

cohort.disease_activity_metadata_available True
Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing.

Section descriptions[0], offset 4300

cohort.non_ibd_controls 10
Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing.

Section descriptions[0], offset 4300

cohort.total_participants 20
Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing.

Section descriptions[0], offset 4300

Specimens

FieldValueEvidence
specimens.number_of_samples 20
Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing.

Section descriptions[0], offset 4300

specimens.sample_type stool inferred
Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing.

Section descriptions[0], offset 4300